Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jutta Beier, Jan van Noord, Amanda Deans, Jean Brooks, Claire Maden, Suus Baggen, Rashmi Mehta & Anthony Cahn. (2012) Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 153-164.
Read now
Read now
Articles from other publishers (10)
Wei Zhou, Ziyi Chen, Aiping Lu & Zhigang Liu. (2021)
Systems Pharmacology-Based Strategy to Explore the Pharmacological Mechanisms of
Citrus
Peel (Chenpi) for Treating Complicated Diseases
. The American Journal of Chinese Medicine 49:02, pages 391-411.
Crossref
Crossref
Antonio Mete, Keith Bowers, Richard J. Bull, Helen Coope, David K. Donald, Katherine J. Escott, Rhonan Ford, Ken Grime, Andrew Mather, Nicholas C. Ray & Vince Russell. (2013) The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD. Bioorganic & Medicinal Chemistry Letters 23:23, pages 6248-6253.
Crossref
Crossref
Eric Bateman, Gregory Feldman, Sally Kilbride, Jean Brooks, Rashmi Mehta, Stephanie Harris, Claire Maden & Glenn Crater. (2012) Efficacy and safety of the long‐acting muscarinic antagonist GSK233705 delivered once daily in patients with COPD. The Clinical Respiratory Journal 6:4, pages 248-257.
Crossref
Crossref
Adam D. Hughes, Alexander McNamara & Tod Steinfeld. 2012. Progress in Medicinal Chemistry Volume 51. Progress in Medicinal Chemistry Volume 51
71
95
.
Gary Phillips & Michael Salmon. 2012. Annual Reports in Medicinal Chemistry Volume 47. Annual Reports in Medicinal Chemistry Volume 47
209
221
.
Antonio Mete, Keith Bowers, Eric Chevalier, David K. Donald, Helen Edwards, Katherine J. Escott, Rhonan Ford, Ken Grime, Ian Millichip, Barry Teobald & Vince Russell. (2011) The discovery of AZD9164, a novel muscarinic M3 antagonist. Bioorganic & Medicinal Chemistry Letters 21:24, pages 7440-7446.
Crossref
Crossref
Paul A. GlossopChristine A. L. WatsonDavid A. PriceMark E. BunnageDonald S. MiddletonAnthony WoodKim JamesDannielle RobertsRoss S. StrangMichael YeadonChristelle Perros-HuguetNicholas P. ClarkeMichael A. TrevethickIan MachinEmilio F. StuartSteven M. EvansAnthony C. HarrisonDavid A. FairmanBalaji AgoramJane L. BurrowsNeil FeederCraig K. FultonBarry R. DillonDavid A. EntwistleFiona J. Spence. (2011)
Inhalation by Design: Novel Tertiary Amine Muscarinic M
3
Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary Disease
. Journal of Medicinal Chemistry 54:19, pages 6888-6904.
Crossref
Crossref
Matthew D SelbyPieter D de Koning & Dannielle F Roberts. (2011) A perspective on synthetic and solid-form enablement of inhalation candidates. Future Medicinal Chemistry 3:13, pages 1679-1701.
Crossref
Crossref
Maria Prat, María Antonia Buil, Maria Dolors Fernández, Jordi Castro, Juan Manuel Monleón, Laia Tort, Gaspar Casals, Manuel Ferrer, Josep Maria Huerta, Sònia Espinosa, Manuel López, Victor Segarra, Amadeu Gavaldà, Montserrat Miralpeix, Israel Ramos, Dolors Vilella, Marisa González, Mònica Córdoba, Alvaro Cárdenas, Francisca Antón, Jorge Beleta & Hamish Ryder. (2011) Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists. Bioorganic & Medicinal Chemistry Letters 21:11, pages 3457-3461.
Crossref
Crossref
Michael J. Stocks, Lilian Alcaraz, Andrew Bailey, Keith Bowers, David Donald, Helen Edwards, Fraser Hunt, Nicholas Kindon, Garry Pairaudeau, Jill Theaker & Daniel J. Warner. (2010) The discovery of new spirocyclic muscarinic M3 antagonists. Bioorganic & Medicinal Chemistry Letters 20:24, pages 7458-7461.
Crossref
Crossref